HIGHLIGHTS
- who: Chiara Di Tucci and collaborators from the Department of Maternal and Child Health and Urological Sciences, Sapienza University, Rome, Italy have published the research: Immune-Onco-Microbiome: A New Revolution for Gynecological Cancers, in the Journal: Microorganisms
- what: This study demonstrated that 7 of 15 cervicovaginal microbiota could be considered a biomarker of OC in premenopausal women.
SUMMARY
Laniewski et_al investigated the association of immune_response with the microbiome in the progression to malignancy for cancer cells. Of 15 Normally, checkpoint proteins, such as Programmed death-ligand 1 (PD-L1) on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.